Indication

Ventricular Tachycardia Pulseless

1 clinical trial

1 product

Clinical trial
CanROC Epinephrine Dose: Optimal Versus Standard Evaluation Trial (CanROC EpiDOSE Trial)
Status: Recruiting, Estimated PCD: 2027-12-01